Navigation Links
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Date:7/12/2010

n of their respective interests in Micrus Endovascular Corporation are set forth in the proxy statement for Micrus Endovascular Corporation's 2009 Annual Meeting of Stockholders, which was filed with the SEC on July 29, 2009, and in any documents subsequently filed by its directors and executive officers under the Securities and Exchange Act of 1934, as amended.  Certain executive officers and directors of Micrus Endovascular Corporation have interests in the proposed transaction that may differ from the interests of stockholders generally, including benefits conferred under retention, severance and change in control arrangements and continuation of director and officer insurance and indemnification.  These interests and any additional benefits in connection with the proposed transaction are described in the definitive proxy statement.

(1) National Stroke Association


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
2. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
3. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
4. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
5. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
6. EF Johnson Technologies Announces Third Quarter Results
7. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
8. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
9. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
10. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
11. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Tenn. , Sept. 16, 2014 A ... investigators has found the chemotherapy dose threshold below ... normal sperm production. The study appears in September 17 ... By clarifying which patients are at highest risk ... findings to eventually increase use of pre-treatment fertility preservation ...
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... , Sept. 16, 2014 Research and Markets ... Vaccines Market 2014-2018" report to their offering. ... immunity of animals. Animal vaccines are generally prepared from weakened ... in their healthy state. Some of the animal vaccines are ... as protein subunits or toxic components. These ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3
... BioStorage Technologies, Inc., a worldwide provider of long- and ... logistics, will expand its European operations with the opening ... full-service biorepository in Frankfurt, Germany. , BioStorage Technologies, expanded ... plan to accommodate a rapidly growing list of customers ...
... Oct. 21 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) ... bavituximab in combination with docetaxel in patients with advanced breast ... planned treatment cycles in the Phase II study showed that ... the trial achieved an objective tumor response according to RECIST ...
Cached Medicine Technology:BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 4
(Date:9/16/2014)... Recently, BamboofloorChina.com, the popular online supplier of elegant ... strand woven bamboo floors to its product catalogue. ... for the new items; the current discount is up ... great shopping season. Therefore, BamboofloorChina.com spares no energy to ... All practical items offered by BamboofloorChina.com are in stock ...
(Date:9/16/2014)... Marybeth Cale, owner of Cale Communications , a public ... small village of Rhinebeck, New York, has announced the launch ... has expanded the business to incorporate a new scope of ... Those services will include group trainings and workshops on a ... clients all over the country. , Workshops address topics ...
(Date:9/16/2014)... 17, 2014 Operation Smile was founded “on ... of a facial deformity.” To spread their message and mission, ... 2014, at the Beverly Wilshire Hotel in Beverly Hills, California. ... worldwide whose lives have been forever transformed by the efforts ... involved with Operation Smile,” said Lynda Erkiletian, Executive Director of ...
(Date:9/16/2014)... On Friday, September 12, Jusuru International ... an accompanying mobile application, the grand-opening of their ... their sales force, and their sponsorship of the ... national convention, Rise to Enterprise 2014 (R2E14). , ... Regency Orange County was treated to a new ...
(Date:9/16/2014)... September 16, 2014 Pulmonary Hypertension Association Travels ... Education Forum for PH Patients and Families to Help Fight ... – the country’s leading pulmonary hypertension association that works to ... a disease of the lungs that affects the functioning of ... treatment, mean survivability is only 2.8 years. , What:, ...
Breaking Medicine News(10 mins):Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3
... Medical School in the South West of England have ... out of hours services in primary care are reluctant ... and carried out telephone interviews with 27 patients who ... practice cover in the evenings and weekends in England. ...
... WANTAGH, N.Y., Nov. 29 As family members age, ... performing daily,tasks, such as cooking and laundry. Some need ... professional medical care, and most,want to stay in the ... how to keep their parents safe, healthy and cared ...
... U.S. is caused by a form of bacteria, the ... It typically begins with a bulls-eye skin rash, accompanied ... If diagnosed early, Lyme can be treated successfully within ... Nearly 60 percent of patients who do not receive ...
... Appointed Worldwide Managing Partners, NEW YORK, Nov. ... the,largest fully integrated, global health marketing and communications ... the credit going to,its unique leadership team whose ... leadership, effective immediately, Doug Burcin and Donna,Murphy, Partners, ...
... -- There are estimated to be ... diagnosed with chronic Immune Thrombocytopenic Purpura (ITP), an ... platelets in their blood -- causing bruises, nosebleeds ... of an international multicenter clinical research study led ...
... Receives Failing Grades on Key Benchmarks, WASHINGTON, ... its first-ever state-specific Report,Card on Lung Cancer. The ... lethal disease by the state of Massachusetts. LCA-MA ... Lung cancer is the number one cause of ...
Cached Medicine News:Health News:Out of hours doctors reluctant to do home visits, say patients 2Health News:Finding Ways for Seniors to Stay Safe, Healthy... and Home 2Health News:Finding Ways for Seniors to Stay Safe, Healthy... and Home 3Health News:Antibody responses in patients with Lyme arthritis 2Health News:Antibody responses in patients with Lyme arthritis 3Health News:World's Largest Fully Integrated, Global Health Marketing and Communications Group Appoints Global Leadership Team 2Health News:World's Largest Fully Integrated, Global Health Marketing and Communications Group Appoints Global Leadership Team 3Health News:Eltrombopag studied in Idiopathic Thrombocytopenic Purpura 2Health News:Lung Cancer Alliance-Massachusetts Issues Inaugural State-Specific Report Card on Lung Cancer 2
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...
Medicine Products: